COVID Vaccine Before ICI Initiation Tied to Increased Survival in Patients With Cancer
COVID Vaccine – A recent study presented at the European Society for Medical Oncology (ESMO) annual meeting has found that administration of a SARS‑CoV‑2 mRNA vaccine within 100 days of initiating immune checkpoint inhibitor (ICI) therapy is associated with significantly improved survival in patients with advanced cancer — specifically those with non‑small cell lung cancer (NSCLC) and metastatic melanoma.